OPK · NASDAQ
Opko Health (OPK) Stock Price & Fundamentals
Opko Health (OPK) closed at $351.51 on Oct 9, 2026, up 1.63% from the previous close of $345.88.
Share price, past year
1Y +4.94%Monthly closing prices
| Date | Close |
|---|---|
| Oct 9, 2026 | $351.51 |
| Sep 30, 2026 | $349.72 |
| Aug 31, 2026 | $366.34 |
| Jul 31, 2026 | $364.65 |
| Jun 30, 2026 | $389.19 |
| May 29, 2026 | $367.73 |
| Apr 30, 2026 | $369.77 |
| Mar 31, 2026 | $368.76 |
| Feb 27, 2026 | $369.10 |
| Jan 30, 2026 | $351.09 |
| Dec 31, 2025 | $356.16 |
| Nov 28, 2025 | $338.88 |
| Oct 31, 2025 | $331.28 |
Key statistics
- Market cap
- $262.34B
- P/E (TTM)
- —
- EPS (TTM)
- −$0.09
- Revenue (TTM)
- $587.90M
- Net income (TTM)
- −$72.89M
- Shares outstanding
- 746.3M
- Dividend yield
- —
- 52-week range
- $330.21 – $389.68
Opko Health's market cap is $262.34B, based on a share price of $351.51 and 746.3M shares outstanding as of Jul 17, 2026.
Financials
Opko Health reported revenue of $606.88M for fiscal 2025, down 14.90% from fiscal 2024.
Opko Health reported a net loss of $225.68M in fiscal 2025.
Annual revenue
| Fiscal year | Revenue | Growth | Net income | Net margin | EPS (diluted) | Free cash flow |
|---|---|---|---|---|---|---|
| FY2025ended Dec 31, 2025 | $606.88M | −14.9% | −$225.68M | −37.2% | −$0.30 | — |
| FY2024ended Dec 31, 2024 | $713.14M | −17.4% | −$53.22M | −7.5% | −$0.08 | — |
| FY2023ended Dec 31, 2023 | $863.50M | −14.0% | −$188.86M | −21.9% | −$0.25 | — |
| FY2022ended Dec 31, 2022 | $1.00B | −43.4% | −$328.41M | −32.7% | −$0.46 | — |
| FY2021ended Dec 31, 2021 | $1.77B | +23.6% | −$30.14M | −1.7% | −$0.05 | — |
| FY2020ended Dec 31, 2020 | $1.44B | +59.2% | $30.59M | 2.1% | $0.05 | — |
| FY2019ended Dec 31, 2019 | $901.94M | −8.9% | −$314.93M | −34.9% | −$0.53 | — |
| FY2018ended Dec 31, 2018 | $990.27M | +2.5% | −$153.04M | −15.5% | −$0.27 | — |
| FY2017ended Dec 31, 2017 | $966.01M | −13.6% | −$305.25M | −31.6% | −$0.55 | — |
| FY2016ended Dec 31, 2016 | $1.12B | — | −$48.36M | −4.3% | −$0.10 | — |
| Quarter | Revenue | Net income | EPS (diluted) |
|---|---|---|---|
| Q2 FY2026ended Jun 30, 2026 | $163.58M | −$8.42M | −$0.01 |
| Q1 FY2026ended Mar 31, 2026 | $124.20M | −$54.85M | −$0.07 |
| Q4 FY2025ended Dec 31, 2025 | $148.45M | −$31.26M | −$0.04 |
| Q3 FY2025ended Sep 30, 2025 | $151.67M | $21.63M | $0.03 |
| Q2 FY2025ended Jun 30, 2025 | $156.81M | −$148.44M | −$0.19 |
| Q1 FY2025ended Mar 31, 2025 | $149.95M | −$67.61M | −$0.10 |
| Q4 FY2024ended Dec 31, 2024 | $183.64M | $14.03M | $0.01 |
| Q3 FY2024ended Sep 30, 2024 | $173.63M | $24.89M | $0.03 |
Company profile
- Name
- Opko Health, Inc.
- Ticker
- OPK
- Exchange
- NASDAQ
- Industry (SEC SIC)
- Pharmaceutical Preparations
- Headquarters
- 4400 Biscayne Blvd., Miami, FL 33137
- Incorporated in
- DE
- Fiscal year ends
- December
- SEC CIK
- 0000944809
Recent SEC filings
- Oct 2, 2026
- Aug 28, 2026
- Aug 28, 2026
- Aug 14, 2026
- Jul 27, 2026
- Jul 27, 2026
- Jun 18, 2026
- Apr 28, 2026
Frequently asked questions
What is Opko Health's stock price?
Opko Health (OPK) closed at $351.51 on Oct 9, 2026, up 1.63% from the previous close of $345.88.
What is Opko Health's market cap?
Opko Health's market cap is $262.34B, based on a share price of $351.51 and 746.3M shares outstanding as of Jul 17, 2026.
How much revenue does Opko Health make?
Opko Health reported revenue of $606.88M for fiscal 2025, down 14.90% from fiscal 2024.
Does Opko Health pay a dividend?
Opko Health's recent filings report no dividends declared over the last four quarters.
Sources and methodology
Fundamentals come from Opko Health, Inc.'s filings with the SEC (EDGAR XBRL company facts). Fourth-quarter figures that companies don't report separately are calculated as the fiscal year minus the first three quarters. Trailing twelve-month (TTM) figures sum the latest four quarters. Prices are generated sample data for development. Last updated Oct 9, 2026. Data sources and disclosures